Literature DB >> 2106004

Free and antibody-complexed antigen and antibody profile in apparently healthy HIV seropositive individuals and in AIDS patients.

M Portera1, F Vitale, R La Licata, D R Alesi, G Lupo, F Bonura, N Romano, G Di Cuonzo.   

Abstract

The pattern of free and antibody-complexed HIV antigen and the antibody profile were investigated retrospectively in 305 serum samples taken from 22 AIDS patients before and during the development of AIDS and from 40 apparently healthy seropositive individuals. Most AIDS patients were found positive for both free and complexed antigen and had high gp41 antibody titres but low or undetectable p24 antibody. Four different patterns of HIV antigenaemia were observed: 1) positive for both free and complexed antigen; 2) negative for free HIV antigen at first, but always positive for complexed antigen; 3) positive for free antigen without complexed antigen; and 4) negative for both free and complexed antigen. The development of immune complexes preceded the appearance of free antigen and might reflect the ongoing viral replication with antigen excess and binding of anticore antibodies. No correlation was found between the development of AIDS symptoms and either the duration of free antigen positivity or the level of antigenaemia. A different pattern was observed in apparently healthy seropositive individuals: 90% of whom had high antibody titres to p24 and gp41 and were persistently negative for free and complexed HIV antigen. This study demonstrates that testing HIV markers in sequentially collected serum samples from HIV seropositive individuals is a useful and simple tool for early identification of persons at risk of developing AIDS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106004     DOI: 10.1002/jmv.1890300107

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection.

Authors:  Pinghuang Liu; R Glenn Overman; Nicole L Yates; S Munir Alam; Nathan Vandergrift; Yue Chen; Frederik Graw; Stephanie A Freel; John C Kappes; Christina Ochsenbauer; David C Montefiori; Feng Gao; Alan S Perelson; Myron S Cohen; Barton F Haynes; Georgia D Tomaras
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

Review 2.  HIV-associated immune complex kidney disease.

Authors:  Ehsan Nobakht; Scott D Cohen; Avi Z Rosenberg; Paul L Kimmel
Journal:  Nat Rev Nephrol       Date:  2016-01-19       Impact factor: 28.314

3.  Increased detection of human immunodeficiency virus antigenemia after dissociation of immune complexes at low pH.

Authors:  R A Pokriefka; O Manzor; N P Markowitz; L D Saravolatz; P Kvale; R M Donovan
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

4.  Stability of free and complexed human immunodeficiency virus type 1 antigen at 4 degrees C and at room temperature.

Authors:  B P Griffith; R B Garner; T M Chacko
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Phase I/II vaccination study of recombinant peptide F46 corresponding to the HIV-1 transmembrane protein coupled with 2.4 dinitrophenyl (DNP) Ficoll.

Authors:  S Schwander; M Opravil; R Lüthy; D G Hanson; J Schindler; A Dawson; B Letwin; M Dietrich
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.